Herpes zoster in Germany: quantifying the burden of disease.

Ultsch, Bernhard; Siedler, Anette; Rieck, Thorsten; Reinhold, Thomas; Krause, Gerard; Wichmann, Ole

dc.contributor.author	Ultsch, Bernhard
dc.contributor.author	Siedler, Anette
dc.contributor.author	Rieck, Thorsten
dc.contributor.author	Reinhold, Thomas
dc.contributor.author	Krause, Gerard
dc.contributor.author	Wichmann, Ole
dc.date.accessioned	2015-11-17T09:49:47Z	en
dc.date.available	2015-11-17T09:49:47Z	en
dc.date.issued	2011	en
dc.identifier.citation	Herpes zoster in Germany: quantifying the burden of disease. 2011, 11:173 BMC Infect. Dis.	en
dc.identifier.issn	1471-2334	en
dc.identifier.pmid	21679419	en
dc.identifier.doi	10.1186/1471-2334-11-173	en
dc.identifier.uri	http://hdl.handle.net/10033/582280	en
dc.description.abstract	Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged≥50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged≥50 years in Germany by utilizing various data sources.
dc.language.iso	en	en
dc.subject.mesh	Aged	en
dc.subject.mesh	Aged, 80 and over	en
dc.subject.mesh	Cost of Illness	en
dc.subject.mesh	Cost-Benefit Analysis	en
dc.subject.mesh	Female	en
dc.subject.mesh	Germany	en
dc.subject.mesh	Herpes Zoster	en
dc.subject.mesh	Herpes Zoster Vaccine	en
dc.subject.mesh	Hospitalization	en
dc.subject.mesh	Humans	en
dc.subject.mesh	Incidence	en
dc.subject.mesh	Male	en
dc.subject.mesh	Middle Aged	en
dc.subject.mesh	Outpatients	en
dc.subject.mesh	Poisson Distribution	en
dc.title	Herpes zoster in Germany: quantifying the burden of disease.	en
dc.type	Article	en
dc.contributor.department	Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.	en
dc.identifier.journal	BMC infectious diseases	en
refterms.dateFOA	2018-06-13T16:58:55Z
html.description.abstract	Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged≥50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged≥50 years in Germany by utilizing various data sources.